-
Mashup Score: 3
Sanam Loghavi and Naval Daver discuss the current approach to the diagnosis and classification, risk-stratification and treatment options for newly diagnosed AML in the context of recurrent genetic alterations.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Using MRD to guide treatment decisions in myeloma - 7 hour(s) ago
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses the potential for using measurable residual disease (MRD) status to guide treatment decisions in clinical practice. Patients with multiple myeloma (MM) who achieve MRD-negativity may be able to discontinue treatment early and undergo a treatment-free interval. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1The current treatment approaches for patients with VEXAS syndrome - 22 hour(s) ago
MaΓ«l Heiblig, MD, HΓ΄pital Lyon Sud, Lyon, France, discusses the current treatment approaches for patients with VEXAS syndrome, which include controlling inflammation, controlling the clone, and supportive care. Dr Heiblig hopes that prospective trials will be initiated in this patient population shortly to assess the safety and efficacy of the treatments being used, as no standard of care currently exists. This interview took place at the European School of Hematology 9th Translational Research Conference on Myelodysplastic Syndromes (ESH MDS) in Budapest, Hungary. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA approves fidanacogene elaparvovec, a one-time gene therapy, for adult patients with hemophilia B - 2 day(s) ago
Read about the FDA approval of fidanacogene elaparvovec, a one-time gene therapy, for adults with hemophilia B.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Highlights from EBMT 2024: treating & managing GvHD & understanding the role of the gut microbiome - 2 day(s) ago
Tune in to this week’s VJHemOnc podcast to learn more about current & emerging treatment options for acute & chronic GvHD, as well as the role of the gut microbiome.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
James Ferrara, MD, DSc, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, introduces a system for the risk stratification of graft-versus-host disease (GvHD) in the gastrointestinal (GI) tract. The MAGIC algorithm probability (MAP) predicts overall mortality at 6 months and response to treatment at day 28 based on the MAGIC composite score, which considers clinical features as well as GvHD biomarkers. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5VJHemOnc β The video journal of hematological oncology - 3 day(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!π We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
-
Mashup Score: 5VJHemOnc β The video journal of hematological oncology - 3 day(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!π We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
-
Mashup Score: 5VJHemOnc β The video journal of hematological oncology - 3 day(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!π We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
-
Mashup Score: 5VJHemOnc β The video journal of hematological oncology - 3 day(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!π We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
We're excited to share some fantastic hemepath case studies with you! Learn more about the diagnosis, risk stratification & treatment of ND-AML with experts @sanamloghavi & @Daver_Leukemia! π https://t.co/D4UkKSmW2l Thank you to Sanam & Naval for working on these with us! https://t.co/uN5Gv2NP0z